Literature DB >> 14602492

Modified CLIP using PIVKA-II for evaluating prognosis after hepatectomy for hepatocellular carcinoma.

A Nanashima1, S Morino, H Yamaguchi, K Tanaka, S Shibasaki, T Tsuji, S Hidaka, T Sawai, T Yasutake, T Nakagoe.   

Abstract

AIMS: The new staging system proposed by the Cancer of the Liver Italian Program (CLIP) for hepatocellular carcinoma (HCC) accounts for both liver dysfunction and tumour characteristics. The present study was designed to analyze UICC TNM stage, CLIP and modified CLIP in 91 patients who underwent hepatic resection for HCC.
METHODS: In the modified CLIP, scoring of AFP was replaced by that of protein induced by vitamin K absence or antagonist II (PIVKA-II; predictive value, > or = 400 mAU/ml).
RESULTS: After hepatic resection, 54 patients developed recurrent tumours. High PIVKA-II was a significant determinant of recurrence (p<0.05). However, a high score of the modified CLIP as well as those other staging systems did not correlate with tumour-recurrence rate. Univariate analysis showed that high TNM score, CLIP score and our modified CLIP score were significant predictors of poor prognosis. Multivariate Cox's analysis revealed that high PIVKA-II and high modified CLIP score were associated with higher risk for disease-free and overall survival as well as high TNM stage.
CONCLUSIONS: Compared with the original CLIP, our modified CLIP was a better predictor of prognosis of HCC patients who underwent hepatic resection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14602492     DOI: 10.1016/j.ejso.2003.08.007

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  10 in total

1.  Tumor marker levels before and after curative treatment of hepatocellular carcinoma as predictors of patient survival.

Authors:  Atsushi Nanashima; Naota Taura; Takafumi Abo; Tatsuki Ichikawa; Ichiro Sakamoto; Takeshi Nagayasu; Kazuhiko Nakao
Journal:  Dig Dis Sci       Date:  2011-06-25       Impact factor: 3.199

2.  Modified Japan Integrated Staging is currently the best available staging system for hepatocellular carcinoma patients who have undergone hepatectomy.

Authors:  Atsushi Nanashima; Yorihisa Sumida; Takafumi Abo; Hisakazu Shindou; Hidetoshi Fukuoka; Hiroaki Takeshita; Shigekazu Hidaka; Kenji Tanaka; Terumitsu Sawai; Toru Yasutake; Takeshi Nagayasu; Katsuhisa Omagari; Mariko Mine
Journal:  J Gastroenterol       Date:  2006-03       Impact factor: 7.527

3.  Preoperative prognostic values of α-fetoprotein (AFP) and protein induced by vitamin K absence or antagonist-II (PIVKA-II) in patients with hepatocellular carcinoma for living donor liver transplantation.

Authors:  Seok-Hwan Kim; Deok-Bog Moon; Wan-Joon Kim; Woo-Hyoung Kang; Jae Hyun Kwon; Eun Kyung Jwa; Hwui-Dong Cho; Su-Min Ha; Yong-Kyu Chung; Sung-Gyu Lee
Journal:  Hepatobiliary Surg Nutr       Date:  2016-12       Impact factor: 7.293

4.  Postoperative changes in protein-induced vitamin K absence or antagonist II levels after hepatectomy in patients with hepatocellular carcinoma: relationship to prognosis.

Authors:  A Nanashima; Y Sumida; S Tobinaga; K Shibata; H Shindo; M Obatake; S Shibasaki; N Ide; Takeshi Nagayasu
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

5.  Selection of treatment modality for hepatocellular carcinoma according to the modified Japan Integrated Staging score.

Authors:  Atsushi Nanashima; Junichi Masuda; Satoshi Miuma; Yorihisa Sumida; Takashi Nonaka; Kenji Tanaka; Shigekazu Hidaka; Terumitsu Sawai; Takeshi Nagayasu
Journal:  World J Gastroenterol       Date:  2008-01-07       Impact factor: 5.742

6.  Des-gamma-carboxy prothrombin as an important prognostic indicator in patients with small hepatocellular carcinoma.

Authors:  Kenichi Hakamada; Norihisa Kimura; Takuya Miura; Hajime Morohashi; Keinosuke Ishido; Masaki Nara; Yoshikazu Toyoki; Shunji Narumi; Mutsuo Sasaki
Journal:  World J Gastroenterol       Date:  2008-03-07       Impact factor: 5.742

Review 7.  Scoring systems for the management of oncological hepato-pancreato-biliary patients.

Authors:  Alexander W Coombs; Chloe Jordan; Sabba A Hussain; Omar Ghandour
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2022-02-28

8.  A K-nearest Neighbor Model to Predict Early Recurrence of Hepatocellular Carcinoma After Resection.

Authors:  Chuanli Liu; Hongli Yang; Yuemin Feng; Cuihong Liu; Fajuan Rui; Yuankui Cao; Xinyu Hu; Jiawen Xu; Junqing Fan; Qiang Zhu; Jie Li
Journal:  J Clin Transl Hepatol       Date:  2022-01-04

9.  Impact of L-type amino acid transporter 3 on the prognosis of hepatocellular carcinoma.

Authors:  Baasansvren Selenge; Shinichiro Yamada; Yuji Morine; Tetsuya Ikemoto; Yu Saito; Chie Takasu; Hiroki Teraoku; Mitsuo Shimada
Journal:  Oncol Lett       Date:  2022-09-30       Impact factor: 3.111

10.  Establishment and Validation of SSCLIP Scoring System to Estimate Survival in Hepatocellular Carcinoma Patients Who Received Curative Liver Resection.

Authors:  Sha Huang; Gui-Qian Huang; Gui-Qi Zhu; Wen-Yue Liu; Jie You; Ke-Qing Shi; Xiao-Bo Wang; Han-Yang Che; Guo-Liang Chen; Jian-Feng Fang; Yi Zhou; Meng-Tao Zhou; Yong-Ping Chen; Martin Braddock; Ming-Hua Zheng
Journal:  PLoS One       Date:  2015-06-09       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.